Main Catalog

AMCP Web Site

Main Catalog

Found 75

Sort By

Member Free

Non-Member $30.00

Drug Pipeline: Traditional Pharmaceuticals and Biosimilars

Contact Hours: 1 - This session focuses on new and emerging traditional pharmaceutical brand-name drugs, as well as upcoming generic and biosimilar drug approvals.

Drug Pipeline

Member Free

Non-Member $30.00

Evaluating Digital Therapeutics, Drugs, and Health Technology for Optimizing Clinical and Financial Outcomes

Contact Hours: 1 - Utilization management practices are applied to medications in many therapeutic areas, but present unique challenges with digital therapeutics (DTx) and digital health tools.

Digital Therapeutics

Member Free

Non-Member $30.00

Health Policy Trends Impacting Managed Care Pharmacy: Are You Ready?

Not Accredited for CPE: Congress, the White House, and presidential candidates are proposing major health policy changes in an election year where health care is a top issue on voters’ minds.

Health Policy

Member Free

Non-Member $30.00

Developing Professional Strategies to Enhance Digital Engagement

Not Accredited for CPE: 2020 will no doubt be the year of digital engagement. On this webinar, Digital Marketing Strategist Eddie Bradley will share tips and insights on how subject matter experts and industry leading brands are leveraging content to grow and further engage with their audience.

Digital Engagement

Member Free

Non-Member $30.00

Cannabis Use in Health Care: What Payers Need to Know

Contact Hours: 1 - Despite a lack of regulatory and legal clarity, significant numbers of patients in Medicare, Medicaid, CHIP, and commercial plans currently use medical cannabis.

Cannabis

Member Free

Non-Member $30.00

Getting Up to Speed on Prescription Drug Pricing Reform Efforts

Contact Hours: 1 - Prescription drug pricing reform is a high-profile issue heading into the 2020 elections. President Trump, members of Congress, and the Democratic presidential candidates.

Drug Pricing

Member Free

Non-Member $30.00

Oncology: Investigating Trends and Elucidating Value

Contact Hours: 1 - Cancer is one of the world’s most pressing health care challenges, with more than 14 million people receiving a cancer diagnosis each year.

Oncology

Member Free

Non-Member $30.00

Placing Potential Cures Within Reach: Real-World Experience and Evolving Management

Contact Hours: 1 - A prominent health care payer and pharmacy benefit manager (PBM) will share their real-world experiences and learnings in managing innovative and expensive gene therapies.

Real World Evidence

Member Free

Non-Member Free

Innovations in Managed Care for Oncology Specialty Pharmacy

Contact Hours: 1 - Benefit designs and management tools promoting high-quality care while simultaneously addressing total cost of care.

Oncology

Member $15.00

Non-Member $30.00

Managing Different Perspectives: Panel Discussion on Integrating Medical and Pharmacy Benefits

Contact Hours: 1 - With several new treatments crossing the traditional dividing lines between medical and pharmacy benefits, there are many questions on how to best manage the coverage for these medications.

Pharmacy Benefits

Member Free

Non-Member Free

Expanding the Managed Care Professional’s Digital Therapeutics IQ

Contact Hours: 1.5. Digital therapeutics are expanding the boundaries of the types of therapies that health care decision-makers must be adept at evaluating.

Digital Therapeutics

Member Free

Non-Member $30.00

Digital Therapeutics: Understanding the Emerging Product Class

Contact Hours: 1 - Digital therapeutics (DTx) are emerging as a novel treatment modality for a wide range of health conditions, either as stand-alone products or for use in conjunction with other treatments.

Digital Therapeutics

Member Free

Non-Member Free

Evolving Oncology Treatment Options— Recent Approvals and a Look to the Future

Contact Hours: 1 - Over 1,100 biopharmaceutical products are currently in the oncology pipeline andnumerous new treatments approved by the FDA each year.

Drug Pipeline Oncology

Member Free

Non-Member Free

Legal and Regulatory Considerations Impacting Oncology Specialty Pharmacy

Contact Hours: 1 - Laws and regulations at the state and federal level that impact oncology care.

Legislation Oncology

Member Free

Non-Member Free

Perspectives on Providing Value in Oncology: A Panel Discussion

Contact Hours: 1 - Perceptions of value in oncology care vary among stakeholders.

Oncology

Member $15.00

Non-Member $30.00

Medicare Part D Bids: How Do Actuaries Get to the Answers?

This session is a recording from AMCP 2021 Virtual.

Medicare and Medicaid

Member $15.00

Non-Member $30.00

Specialty Pipeline and Forecasts 2021

This session is a recording from AMCP 2021 Virtual.

Drug Pipeline Specialty

Member $15.00

Non-Member $30.00

2021 Federal and State Legislative and Regulatory Update

This session is a recording from AMCP 2021 Virtual.

Legislation

Member $15.00

Non-Member $30.00

Medicare Part D: Past, Present and Future

This session is a recording from AMCP 2021 Virtual. It is not accredited for continuing pharmacy education (CPE) credit.

Medicare and Medicaid

Member Free

Non-Member $30.00

The Times They Are a-Changin – A Look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs

Contact Hours: 1.5. For more than a decade, millions of American seniors have been able to access prescription drugs through market-driven programs.

Medicare and Medicaid Health Care Reform

Member Free

Non-Member $30.00

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.

Value-Based Contracting Alzheimer's

Member $15.00

Non-Member $30.00

Federal and State Legislative and Regulatory Update Home Study Nexus 2020

Contact Hours: 1 - In today’s world there are many uncertainties, especially with the COVID-19 pandemic, but health care legislation and regulation continue to move at a staggering pace.

Legislation

Member $15.00

Non-Member $30.00

Keeping Up with Rare Disease Therapies: Pipeline to Management Solutions Track

Contact Hours: 1 - Over the last several years, payers have increased their focus on the management of rare diseases.

Drug Pipeline Rare Diseases

Member $15.00

Non-Member $30.00

Value-Based Payment Models: Opportunities to Integrate Pharmacists from a Variety of Practice Settings

Contact Hours: 1 - Shared savings plans can mitigate health care costs, but how do we establish the relationships required for their success?

Value-Based Contracting

Member $15.00

Non-Member $30.00

The Role of Health Disparities and Social Determinants of Health in Promoting Health and Health Equity

Contact Hours: 1 - Health care disparities are often viewed through the lens of race/ethnicity and socioeconomic status.

Health Disparities Social Determinants

Member $15.00

Non-Member $30.00

Keeping Up with State Legislators: Legislative Updates and Outlook

Contact Hours: 1 - The COVID-19 pandemic had a significant impact on state legislation and regulation.

Legislation

Member $15.00

Non-Member $30.00

How is Real-World Evidence in Oncology Used by Payers in Decision-Making? Home Study

Contact Hours: 1 - Payers face significant and growing costs with oncology treatments.

Oncology Real World Evidence

Member Free

Non-Member $30.00

Biosimilars in the United States: Barriers, Solutions, Real-World Evidence, and the Experience of One Health System

Contact Hours: 1.5. As of July 2019, the U.S. Food and Drug Administration (FDA) had approved 25 biosimilar or follow-on biologic products.

Real World Evidence Biosimilars

Member Free

Non-Member $50.00

Addressing Equity in the Management of COVID-19: A Managed Care Perspective

This webcast is a recording from AMCP eLearning Days 2021.

Equity Covid-19

Member Free

Non-Member Free

Navigating Changes in Clostridioides difficile Prevention and Treatment- Journal Supplement

Clostridioides difficile (C. diff, previously known as Clostridium difficile) infections are a major health care concern. This journal CPE activity offers 1.5 CPE.

C. Diff

Member Free

Non-Member Free

The Evidence Behind COVID-19 Treatments and Vaccines

Contact Hours: 1.0 - COVID-19 has caused significant social and economic disruptions around the world.

Covid-19

Member Free

Non-Member Free

The Heavy Burden of Obesity Management in Health Care

The activity is jointly provided by AMCP, Impact Education and the Postgraduate Institute for Medicine.

Obesity

Member Free

Non-Member Free

PrEPing for Change: The Impact of PrEP Guideline Updates for Preventing HIV Infections

Contact Hours: 1 - Effective prevention strategies for HIV infection are an important public health priority.

HIV

Member Free

Non-Member Free

Navigating Changes in Clostridioides difficile Prevention and Treatment

Contact Hours: 1. 5 - Clostridioides difficile (C. diff, previously known as Clostridium difficile) infections are a major health care concern.

C. Diff

Member Free

Non-Member Free

Heart Failure: Advances in Medications and Technology

Contact Hours: 1. 0 - Heart failure (HF) is one of the costliest diseases in the United States.

Heart Failure

Member $15.00

Non-Member $30.00

White and Brown Bagging: Emerging Practice, Legislative and Board of Pharmacy Trends

Contact Hours: 1 - The growth of specialty pharmacy has resulted in an increase of white bagging and brown bagging.

Brown Bagging

Member Free

Non-Member $69.00

Health Care Trends and the Impact of COVID-19

Not Accredited for CPE: The COVID-19 global pandemic has had a tremendous impact on the health care community. As the pandemic continues, it is vital to remain informed on how it has affected overall health care trends and, specifically, how those trends have impacted managed care pharmacy.

Covid-19

Member Free

Non-Member $30.00

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.

Social Determinants

Member Free

Non-Member $30.00

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.

Specialty Drug Spend

Member Free

Non-Member $50.00

The FDA Expedited Approval Pathways: Considerations for Real-World Effectiveness and Health Plan Design

This webcast is a recording from AMCP eLearning Days 2021.

Real World Evidence

Member Free

Non-Member $50.00

ICER Reports: New Developments and Applications in Managed Care Pharmacy

This webcast is a recording from AMCP eLearning Days 2021.

ICER

Member Free

Non-Member $50.00

Shooting for the Stars! The Crucial Role of Health Care Partner Collaboration in Medicare Star Ratings

This is webcast is a recording from AMCP eLearning Days 2021.

Medicare and Medicaid

Member Free

Non-Member $50.00

AMCP Talks: Success Stories in Biosimilar Adoption

This webcast is a recording from AMCP eLearning Days 2021. Please note it is NOT accredited for CPE.

Biosimilars

Member Free

Non-Member $50.00

Addressing Racial Disparities in Medication Adherence

This webcast is a recording from AMCP eLearning Days 2021.

Health Disparities

Member Free

Non-Member $30.00

Specialty Pharmaceuticals in Development - Nexus 2019

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.

Specialty

Member $15.00

Non-Member $30.00

Impact of Prescription Drug Reference Pricing on Drug Spend and Utilization

Contact Hours: 1 - Prescription drug reference pricing is an emerging pharmacy benefit management tool that aligns plan reimbursement to clinical value.

Drug Pricing

Member $15.00

Non-Member $30.00

Overcoming Barriers to Biosimilar Adoption through Coordinated Efforts

Contact Hours: 1 - Biosimilars are considered a fundamental pillar to containing drug spend in today’s health care systems.

Biosimilars

Member $15.00

Non-Member $30.00

Population Management: Zooming in on Rare Diseases with ICER Reports

Contact Hours: 1 - An estimated 10% of the population has a rare disease, according to the National Organization of Rare Disorders (NORD), which lists over 1,200 rare diseases.

ICER

Member $15.00

Non-Member $30.00

Specialty Pharmaceuticals in Development Nexus 2020

Contact Hours: 1 - Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.

Specialty

Member $15.00

Non-Member $30.00

The Evolving Role of Managed Care in the Gene Therapy Era: Focus on Hemophilia

Contact Hours: 1 - The first gene therapies for hemophilia A and B are expected to reach the market by 2022, with more projected in the coming years.

Gene Therapy

Main Catalog

Error